AGER and endothelial dysfunction: The receptors for the advanced glycation end products (RAGE), on endothelial cells, further inhibit the endothelial nitric oxide synthase, thereby contributing to endothelial dysfunction [8], atherosclerotic processes, and a variety of microvascular and macrovascular complications [9].